NUCLEIC ACID RESEARCH INST has a total of 26 patent applications. Its first patent ever was published in 1987. It filed its patents most often in United States, Australia and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and machines are JANSSEN PRODUCTS LP, Changzhou fangyuan pharmaceutical co ltd and BONTAC BIO ENGINEERING SHENZHEN CO LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 6 | |
#2 | Australia | 3 | |
#3 | EPO (European Patent Office) | 3 | |
#4 | WIPO (World Intellectual Property Organization) | 3 | |
#5 | Denmark | 2 | |
#6 | Spain | 2 | |
#7 | Norway | 2 | |
#8 | Canada | 1 | |
#9 | Greece | 1 | |
#10 | Republic of Korea | 1 | |
#11 | Mexico | 1 | |
#12 | New Zealand | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Machines |
# | Technology | |
---|---|---|
#1 | Sugars | |
#2 | Therapeutic chemical compounds | |
#3 | Medical preparations | |
#4 | Unspecified technologies |
# | Name | Total Patents |
---|---|---|
#1 | Robins Roland K | 17 |
#2 | Revankar Ganapathi R | 13 |
#3 | Chang Yu-An | 11 |
#4 | Robins Roland Kenith | 6 |
#5 | Hanna Naeem Botros | 5 |
#6 | Revankar Ganapathi Ramakrishma | 3 |
#7 | Kini Ganesh D | 2 |
#8 | Hanna Naeem B | 2 |
#9 | Revanker Ganapathi R | 2 |
#10 | Kenith Roland Robins | 1 |
Publication | Filing date | Title |
---|---|---|
DK394989D0 | Purines, preparations for preparing them and pharmaceutical preparations containing such a relationship | |
US4992426A | Antiparasitic 5'-sulfamoyl nucleosides | |
CA1317291C | Antitumor 6-sulfenamide, 6-sulfinamide and 6-sulfonamide purines, purine nucleosides, purine nucleotides and related compounds | |
US5026836A | 6-sulfenamide, 6-sulfinamide and 6-sulfonamide purines, purine nucleosides, purine nucleotides, pharmaceutical compositions, and processes of making | |
US4925930A | Synthesis and anti-leukemic activity of alkyl-1-(β-D-ribofuranosyl)[1,2,4]triazole-3-carboximidates | |
US4950647A | T cell immunopotentiator | |
US5041542A | Substituted pyrimido[5,4-d]pyrimidine nucleosides | |
AU1933588A | Treatment of malignant tumors with 8-aminoadenosine 3',5'-cyclic phosphate and combinations of 8-aminoadeno- sine 3',5'-cyclic phosphate and 8-chloroadenosine 3',5'- cyclic phosphate | |
US4861873A | 8-Chloroadenosine 3', 5'-cyclic monophosphate preparations |